Werewolf Therapeutics (HOWL) Change in Accured Expenses (2020 - 2026)

Werewolf Therapeutics has reported Change in Accured Expenses for 7 years, with the latest figure at -$221000.0 in Q2 2026.

• Change in Accured Expenses for Q2 2026 came in at -$221000.0, down 121.71% year-over-year; the trailing twelve-month figure through Jun 2026 was -$3.4 million (down 415.75% YoY), and the FY2025 annual result was -$7.5 million, down 317.02% from the prior year.
• Change in Accured Expenses retreated to -$221000.0 in Q2 2026, from $1.9 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $5.6 million in Q2 2022 and troughed at -$3.9 million in Q4 2025.
• A 5-year average of -$201666.7 and a median of $314000.0 in 2024 frame the typical range for Change in Accured Expenses.
• The widest annual swing landed in 2022, when Change in Accured Expenses surged 327.62%; it then sank 373.42% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at -$1.6 million in 2022, then jumped by 158.43% to $953000.0 in 2023, then surged by 171.88% to $2.6 million in 2024, then plunged by 252.26% to -$3.9 million in 2025, then surged by 94.4% to -$221000.0 in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$221000.0 in Q2 2026, $1.9 million in Q1 2026, and -$3.9 million in Q4 2025.